APIE Therapeutics
APIE Therapeutics is a pre-clinical stage company developing a portfolio of anti-fibrotic small molecule therapeutics to treat diseases associated with injury to the vascular endothelium organ and fibrogenesis.
Alert Banner
Alert:Watch the Boston Globe Today’s video on why North Carolina is an attractive place to grow a life sciences business, including lower business costs and highly skilled workforce.
Close Search Window
